1.
Wardhani SO, Susanti H, Rahayu P, Yueniwati Y, Fajar J. The Levels of FoxO3a Predict the Failure of Imatinib Mesylate Therapy among Chronic Myeloid Leukemia Patients. Open Access Maced J Med Sci [Internet]. 2021 Apr. 29 [cited 2024 Apr. 24];9(B):255-9. Available from: https://oamjms.eu/index.php/mjms/article/view/5852